Pro-inflammatory and anti-inflammatory mediators regulate pulmonary inflammation, and PVL toxins induce the release of specific pro-inflammatory agents such as histamine, leukotriene B4, and IL-8 by activating neutrophils and other granulocytes. The gene discussed is CXCL8; the disease is inflammatory response.